Faculty
-
August 30, 2016
Robert Klitzman on EpiPen's Price Hike
With EpiPen price-gouging in the news, Columbia's School of Professional Studies Bioethics Program Director, Dr. Robert Klitzman, has a new op-ed in CNN about the ethical questions raised by drug companies' overcharging patients. It's a tangled story of the principles of medicine, the profit priorities of private companies, and the taxpayers' money that creates these innovations.
Read the full article at CNN.
Faculty
Why measuring individual engagement alone no longer captures how organizations actually perform.
Faculty
ERM part-time lecturer Corey Hirsch examines what PHP2Shell reveals about the fragility of modern digital infrastructure and how AI-driven vulnerability discovery is reshaping cybersecurity risk management.
Faculty
PlaNYC 2030 reshaped NYC’s approach to urban planning, environmental policy, & climate resilience.
All News
